PageOverview.com
 

Websites, domains, hosts that links to pi.shirecontent.com

Our database shows, that the website pi.shirecontent.com is linked by a total of 15 websites.

 
Number of websites/domains displayed: 15
Results found: 15
 

Websites discovered:

Treatment: ADHD & Moderate to Severe B.E.D. in Adults
http://pageoverview.com/website-report/udotherest.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
  • Expected expiration: June 21st in 2017
  • Creation date: June 21st in 2011
  • Renew date: May 25th in 2016
Ulcerative Colitis (UC) Treatment | Lialda® (mesalamine)
http://pageoverview.com/website-report/lialda.com
Check out Lialda for induction of remission in active mild to moderate UC and maintenance of UC remission. Read safety info including potential kidney problems.
  • Expected expiration: June 20th in 2018
  • Creation date: June 20th in 2005
  • Renew date: May 24th in 2017
Treatment: ADHD & Moderate to Severe B.E.D. in Adults
http://pageoverview.com/website-report/shireregistration.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
  • Expected expiration: December 11th in 2017
  • Creation date: December 11th in 2013
  • Renew date: November 17th in 2016
FIRAZYR® (icatibant injection)
http://pageoverview.com/website-report/firazyr.com
The official website of FIRAZYR® (icatibant injection) by Shire. Learn more about associated risks and benefits, including important safety information.
  • Expected expiration: November 22nd in 2018
  • Creation date: November 22nd in 2005
  • Renew date: October 30th in 2017
Concerned About ADHD symptoms?
http://pageoverview.com/website-report/vyvanseadult.com
What are ADHD symptoms? Do ADHD symptoms differ by settings? Talk to your doctor. See Important Safety Information & Warning about Abuse and Dependence.
  • Expected expiration: December 19th in 2017
  • Creation date: December 19th in 2007
  • Renew date: November 22nd in 2016
PENTASA® (mesalamine) Official Web Site
http://pageoverview.com/website-report/pentasaus.com
  • Expected expiration: July 22nd in 2018
  • Creation date: July 22nd in 2003
  • Renew date: June 25th in 2017
ADHD in Children
http://pageoverview.com/website-report/vyvansekids.com
Find information on ADHD in children (6-17). See Important Safety Information & Warning About Abuse and Dependence.
  • Expected expiration: December 19th in 2017
  • Creation date: December 19th in 2007
  • Renew date: November 22nd in 2016
Vyvanse® (lisdexamfetamine dimesylate) CII for moderate to severe B.E.D. in adults & ADHD
http://pageoverview.com/website-report/shireadhd.com
Information about a treatment for ADHD and moderate to severe binge eating disorder in adults. Limitation against use for weight loss. See Important Safety Info & Boxed Warning about Abuse and Dependence.
  • Expected expiration: June 20th in 2018
  • Creation date: June 20th in 2007
  • Renew date: May 24th in 2017
Treatment: ADHD & Moderate to Severe B.E.D. in Adults
http://pageoverview.com/website-report/vyvanse.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
  • Expected expiration: October 24th in 2017
  • Creation date: October 24th in 2006
  • Renew date: September 27th in 2016
Vyvanse® (lisdexamfetamine dimesylate) CII - HCP Site
http://pageoverview.com/website-report/vyvansepro.com
An ADHD and moderate to severe B.E.D in adults treatment. Limitation against use for weight loss. See Important Safety Info & Boxed Warning about Abuse and Dependence.
  • Expected expiration: April 21st in 2018
  • Creation date: April 21st in 2009
  • Renew date: March 25th in 2017
Registration
http://pageoverview.com/website-report/vyvansesavings.com
  • Expected expiration: June 18th in 2017
  • Creation date: June 18th in 2010
  • Renew date: May 22nd in 2016
Treatment: ADHD & Moderate to Severe B.E.D. in Adults
http://pageoverview.com/website-report/theydotherest.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
  • Expected expiration: August 10th in 2017
  • Creation date: August 10th in 2011
  • Renew date: July 14th in 2016
CINRYZE® (C1 esterase inhibitor [human])
http://pageoverview.com/website-report/cinryze.com
  • Expected expiration: April 3rd in 2018
  • Creation date: April 3rd in 2007
  • Renew date: March 8th in 2017
Official HCP Site: MYDAYIS® (mixed salts of a single-entity amphetamine product)
http://pageoverview.com/website-report/mydayis-pro.com
  • Expected expiration: July 20th in 2018
  • Creation date: July 20th in 2017
  • Renew date: July 25th in 2017
Vyvanse® (lisdexamfetamine dimesylate) Copay Information
http://pageoverview.com/website-report/vyvansecopay.com
Find your copay information. See Important Safety Info & Warning regarding Potential for Abuse and Dependence.
  • Expected expiration: November 8th in 2018
  • Creation date: November 8th in 2013
  • Renew date: October 12th in 2017
0.0196 // 2024-05-08 17:42:55
All Rights reserved 2018 © PageOverview.com